Last Updated: November 8, 2026

LIDOSITE TOPICAL SYSTEM KIT Drug Patent Profile

« Back to Dashboard


Which patents cover Lidosite Topical System Kit, and what generic alternatives are available?

Lidosite Topical System Kit is a drug marketed by Vyteris and is included in one NDA.

The generic ingredient in LIDOSITE TOPICAL SYSTEM KIT is epinephrine; lidocaine hydrochloride. There is one drug master file entry for this compound. Twelve suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for LIDOSITE TOPICAL SYSTEM KIT?
  • What are the global sales for LIDOSITE TOPICAL SYSTEM KIT?
  • What is Average Wholesale Price for LIDOSITE TOPICAL SYSTEM KIT?
Summary for LIDOSITE TOPICAL SYSTEM KIT
US Patents:0
Applicants:1
NDAs:1
DailyMed Link:LIDOSITE TOPICAL SYSTEM KIT at DailyMed

US Patents and Regulatory Information for LIDOSITE TOPICAL SYSTEM KIT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vyteris LIDOSITE TOPICAL SYSTEM KIT epinephrine; lidocaine hydrochloride PATCH;IONTOPHORESIS, TOPICAL 021504-001 May 6, 2004 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for LIDOSITE TOPICAL SYSTEM KIT

International Patents for LIDOSITE TOPICAL SYSTEM KIT

See the table below for patents covering LIDOSITE TOPICAL SYSTEM KIT around the world.

Country Patent Number Title Estimated Expiration
Australia 3019992 ⤷  Start Trial
Australia 655859 ⤷  Start Trial
Canada 2084734 SYSTEME D'IONTOPHORESE DONT LES CARACTERISTIQUES REDUISENT L'IRRITATION CUTANEE (IONTOPHORESIS SYSTEM HAVING FEATURES FOR REDUCING SKIN IRRITATION) ⤷  Start Trial
Germany 69225387 ⤷  Start Trial
European Patent Office 0547482 Système d'ionophorese comportant des moyens de réduction de l'irritation de la peau (Iontophoresis system having features for reducing skin irritation) ⤷  Start Trial
Japan H05245214 ⤷  Start Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.